(ARNA - Free Report
) was a big mover last session, as the company saw its shares jump nearly 11% on the day. This surge can be attributable to solid volume with far more shares changing hands than in a normal session. This broke the recent trend of the company, as the stock is now trading above the volatile price range of $4.08 to $4.75 in the past one-month time frame.
In the last 30 days, the company did not witness any estimate revisions and the Zacks Consensus Estimate has hit a plateau. However, the recent price action is encouraging, so make sure to keep a close watch on this firm in the near future.
Arena Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP
Some better performing biopharmaceutical stocks include Heska Corporation
(HSKA - Free Report
) , Actelion Ltd.
and AMAG Pharmaceuticals, Inc.
(AMAG - Free Report
) . All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>